Navigation Links
Omeros is Not Aware of Any Justification for Share Price Movement
Date:11/13/2012

SEATTLE, Nov. 13, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) has noted the fall in its share price over the last week of trading.  Omeros is not aware of any reason that justifies this decrease. As disclosed in Omeros' recent press releases and its Quarterly Report on Form 10-Q filed on November 9, 2012 with the US Securities and Exchange Commission, Omeros' business, including its clinical programs and its preclinical pipeline, remains on track and the Company is pleased with its progress.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.


'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Mass. , Feb. 27, 2015  Boston Scientific ... participate in the Barclays 2015 Annual Healthcare Conference on ... Dan Brennan , executive vice president ... vice president, Investor Relations, will participate in a 25-minute ... host analyst at approximately 1:05 p.m. ET. Following a ...
(Date:2/27/2015)... Feb. 27, 2015   Synageva BioPharma Corp. ... company developing therapeutic products for rare diseases, joins ... European Organisation for Rare Diseases™ (EURORDIS™), The Global ... observing Rare Disease Day. On the ... industry, and other participants conduct special events to ...
(Date:2/27/2015)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... results for its first quarter ended December 31, 2014. ... 31, 2014, revenue was $1,336,685. Operating expenses were $1,063,393. ... per share.  Covalon,s President and CEO, ... with the significant progress we have made over the ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... part of the brain first,affected by Alzheimers disease ... a risk gene for the disorder, a brain,imaging ... Mental,Health (NIMH), one of the National Institutes of ... structure in the lower middle,part of the brains ...
... 25, 2007 - Reata,Pharmaceuticals, Inc. today announced ... company's Synthetic Triterpenoid programs in,the May 2007 ... The article, "Triterpenoids and rexinoids as multifunctional,agents ... by researchers,and Reata scientific collaborators from the ...
Cached Medicine Technology:Cortex Area Thinner in Youth with Alzheimers-Related Gene 2Cortex Area Thinner in Youth with Alzheimers-Related Gene 3Cortex Area Thinner in Youth with Alzheimers-Related Gene 4Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 2Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 3Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 4
(Date:2/28/2015)... (PRWEB) February 28, 2015 The MCA ... across Malaysia into one platform and gears towards the ... , A series of group talks in smaller groups ... Nation Building, Education, Personal Development, Leadership, Entrepreneurship, Healthcare, Social ... raise awareness of Malaysian youths. , Young ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... BC (PRWEB) February 28, 2015 Vancouver personal ... personal injury claims are affected by time limits. They stated ... weaken a person’s claim or even nullify it. Many a ... effects on a client’s rights under BC law. As a ... are affected by accidents should consult a personal injury lawyer ...
(Date:2/28/2015)... Pioneer Millworks reclaimed USA wood will ... Construction Materials Show, an annual, premier sustainable building event ... and top manufacturers of the latest building products, services ... sourced and manufactured by Pioneer Millworks from their Oregon ... at restaurants, hotels, retailers, and corporate offices. Nichibi ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at ... and current student obtaining her Masters degree in social ... forum in psychoeducation on substance use for teens at ... part of her studies. , “Even though these students ... counseling at the high school and junior high school ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2
... a stroke could run a further risk of further strokes ... a new study. Recurrent// strokes could also disable nearly 50% ... the University at Chicago said” Stroke incidence and mortality are ... of this risk may be explained by a greater vascular ...
... cases of E. coli have been confirmed in Wisconsin, ... been caused by bagged spinach. One person has ... ,Governor Doyle said that 15 of the 30 ... are battling severe infection. Majority of the patients are ...
... chronic disease – myositis -- will speak to congressional staff ... the staff// hearing them on this day – designated 'Myositis ... this little-known and poorly understood disease. Internationally-known male model and ... personal friend, who is prominent in Europe and has the ...
... ever-rising obesity rates all over the world sparking many lifestyle ... just be what the doctor ordered. A pill// is soon ... risk. A mere consumption of the pill once or twice ... better glucose management, thus offsetting diabetes. ,The ...
... study at the Mayo Clinic has found that injecting an ... ,Men with abnormal digital rectal exams or elevated ... usually get prostate biopsies done. ,Nearly 16% pf the patients ... biopsy, according to a new study presented at the annual ...
... 42nd Annual Meeting of the European Association for the ... HCl), an oral// antidiabetic medication, demonstrated significant cardiovascular benefits ... C and acute coronary syndrome in patients with type ... leading cause of premature death in patients with diabetes. ...
Cached Medicine News:Health News:ACTOS Linked to Several Cardiovascular Benefits 2Health News:ACTOS Linked to Several Cardiovascular Benefits 3Health News:ACTOS Linked to Several Cardiovascular Benefits 4
... The EXOGEN 2000+ device provides a ... nonunion or the acceleration of fresh ... home for 20 minutes daily, or ... your physician determines your fracture to ...
Guardsman Femoral Interference Screw is specifically designed for endoscopic femoral fixation where graft protection is needed....
... Interference Screw is indicated for graft ... and PCL reconstructions with bone-patellar tendon-bone ... The SmartScrew ACL provides easy and ... for any graft type. The unique ...
... the TrueView II design, a new generation ... small joint arthroscopy is available. The new ... durable thanks to Olympus advanced fibre technology. ... means bright images, brilliant colour reproduction, high ...
Medicine Products: